Prenetics Global (Prenetics Global) Total Stockholders Equity : $206.36 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Total Stockholders Equity?

Prenetics Global's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $206.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Prenetics Global's Book Value per Share for the quarter that ended in Dec. 2023 was $16.91. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Prenetics Global's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.01.

Prenetics Global Total Stockholders Equity Historical Data

The historical data trend for Prenetics Global's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Total Stockholders Equity Chart

Prenetics Global Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

31.08

-400.81

237.06

206.36

Prenetics Global Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial									237.06	228.25	215.31	224.44	206.36

Prenetics Global (NAS:PRE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Prenetics Global's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(206.358	-	0)	/	12.2052
	=	16.91

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Prenetics Global's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.502	+	0.867)	/	206.358
	=	0.01

Prenetics Global Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Prenetics Global (Prenetics Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG

Website

https://www.prenetics.com

Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.